BioHarvest Sciences Inc. February 2025 Financial Report - Key Insights & Updates

Here are the key insights extracted from the financial report section you provided:

1. Form Type: The document is a Form 6-K, which is a report of a foreign private issuer submitted to the SEC under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
2. Company Information:

• Name: BioHarvest Sciences Inc.
• Commission File Number: 000-56663
• Address: 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

3. Reporting Period: The report is for the month of February 2025.
4. Exhibits:

• Exhibit 99.1: Contains a news release dated February 18, 2025, which likely includes important updates or announcements relevant to the company's operations or financial status.

5. Signature and Authorization:

• The report is signed by David Ryan, who serves as the Vice-President, Investor Relations & Secretary of BioHarvest Sciences Inc.
• The date of the report is February 18, 2025.

6. Regulatory Compliance: The registrant has confirmed compliance with the Securities Exchange Act of 1934, indicating that all necessary disclosures have been made.

These points summarize the critical information contained within the provided section of the financial report, specifically focusing on compliance, corporate identity, and key documents associated with it. Further details about the news release or financial performance would likely be found in the referenced exhibit.